Adalimumab in JIA-associated Uveitis Stopping Trial
Summary
- Eligibility
- for people ages 2 years and up (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Nisha Acharya, MD MSJohn Gonzales, MDThuy Doan, MD PhD
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientists at UCSF
- Nisha Acharya, MD MS
Nisha Acharya is the Director of the Uveitis and Ocular Inflammatory Disease Service and the Uveitis Fellowship at the F.I. Proctor Foundation. Her clinical expertise is the diagnosis and management of patients with infectious and inflammatory eye diseases. She is experienced with the latest treatments for uveitis, including treatment with new immunomodulatory drugs and biologic therapies. - John Gonzales, MD
Associate Professor, Proctor Foundation. Authored (or co-authored) 64 research publications. Research interests: Uveitis · primary vitreoretinal lymphoma · herpetic eye disease · dry eye · Sjögren's syndrome. - Thuy Doan, MD PhD
Associate Professor, Proctor Foundation. Authored (or co-authored) 65 research publications.
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Nisha Acharya
- ID
- NCT03816397
- Phase
- Phase 4
- Study Type
- Interventional
- Last Updated